학술논문
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial
Document Type
Article
Author
Loverix, L.; Vergote, I.; Busschaert, P.; Vanderstichele, A.; Van Nieuwenhuysen, E.; Baert, T.; Han, S.; Neven, P.; Berteloot, P.; Olbrecht, S.; Laga, T.; Van Gorp, T.; Venken, T.; Boeckx, B.; Sablon, E.; Lambrechts, D.; Harter, P.; Brems, H.; Pignata, S.; Gonzalez-Martin, A.; Marth, C.; Colombo, N.; Mäenpää, J.; Ray-Coquard, I.; Pujade-Lauraine, E.
Source
In: European Journal of Cancer . (European Journal of Cancer, July 2023, 188:131-139)
Subject
Language
English
ISSN
18790852
09598049
09598049